A week in tech

A round-up of all the key tech news in Asia.

A week in Japan tech

Life Sciences

- Merck's $1.5 billion takeover of Banyu Pharmaceutical takes another turn, eight days before the U.S. drug giant's offer expires. A Banyu shareholder who contends that he has acquired enough support from other shareholders to block the deal says he sent a letter to the Japanese firm, urging it to oppose Merck's offer. It also requests that Banyu immediately hire an independent financial adviser.

- Oji Paper first in the world to complete genome sequencing of the eucalyptus tree, and says it has created its own database of eucalyptus genome information and plans to file for a patent on the database. Analysis...

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222